Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy

17 Mar 2022

Abstract excerpt

Deficiency in DNA damage response (DDR) genes leads to impaired DNA repair functions that will induce genomic instability and facilitate cancer development. However, alterations of DDR genes can serve as biomarkers for the selection of suitable patients to receive specific therapeutics, such as immune checkpoint blockade (ICB) therapy. In addition, certain altered DDR genes can be ideal therapeutic targets...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to interferon and immune responses
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35328658
DOI: 10.3390/ijms23063238

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting DNA Damage Response and Immune Checkpoint for Anticancer TherapyPMID 35328658Read ↗

DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining ImmunotherapySemantic proximity Read ↗

Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical ApplicationsSemantic proximity Read ↗

Therapeutic Targeting of DNA Damage Response in CancerSemantic proximity Read ↗

Targeting DNA Damage Response and Repair Genes to Enhance Anticancer Immunotherapy: Rationale and Clinical ImplicationSemantic proximity Read ↗

Targeting the DNA damage response in cancerSemantic proximity Read ↗

Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.Semantic proximity Read ↗

The crosstalk between DNA-damage responses and innate immunitySemantic proximity Read ↗

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategiesSemantic proximity Read ↗

Molecular landscape and clinical translation of DNA damage response alterations in solid tumors: A pan-cancer perspective on precision oncology.Semantic proximity Read ↗

Targeting the loss of cGAS / STING signaling in cancerSemantic proximity Read ↗

Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy.Semantic proximity Read ↗

DNA repair in cancer: emerging targets for personalized therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.